(San Francisco, CA) The California Institute of Regenerative Medicine “CIRM” is gearing up for another multibillion-dollar bond raise. President and CEO Maria Millan, MD states that CIRM continues “… to play an extremely important role of boldly investigating early and de-risking these…” stem cell therapy protocols.
California’s Stem Cell Program Faces an Existential Moment — And a Chance for Reform (Los Angeles Times)
